PMC:7029448 / 138-694 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"6","span":{"begin":191,"end":200},"obj":"Species"},{"id":"7","span":{"begin":26,"end":59},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"tao:has_database_id","subj":"6","obj":"Tax:2697049"},{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":38,"end":59},"obj":"Disease"},{"id":"T2","span":{"begin":50,"end":59},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":109,"end":114},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T2","span":{"begin":357,"end":362},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T3","span":{"begin":393,"end":394},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers."}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":115},"obj":"Sentence"},{"id":"T4","span":{"begin":116,"end":292},"obj":"Sentence"},{"id":"T5","span":{"begin":293,"end":392},"obj":"Sentence"},{"id":"T6","span":{"begin":393,"end":457},"obj":"Sentence"},{"id":"T7","span":{"begin":458,"end":556},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers."}